From Name:
From Email:
To Name:
To Email:

Optional Message:


CardioCell stem cells 'improve well-being' of heart failure patients

from FierceBiotech

Since Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver and over the weekend posted broadly positive data. But questions, and the need for more clinical data, remain. The San Diego-based biotech has published new top-line data from the ESC Congress in Rome that used its allogeneic mesenchymal stem cells, delivered through an IV, to heart failure patients with nonischemic cardiomyopathy. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063